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ABSTRACT 31 
The cough reflex becomes hyper-responsive in acute and chronic respiratory diseases, but 32 
understanding the underlying mechanism is hampered by difficulty accessing human tissue 33 
containing both nerve endings and neuronal cell bodies. We refined an adult stem-cell 34 
sensory neuronal model to overcome the limited availability of human neurones and applied 35 
the model to study transient receptor potential ankyrin 1 (TRPA1) channel expression and 36 
activation. 37 
Human dental pulp stem cells (hDPSCs) were differentiated towards a neuronal phenotype, 38 
termed peripheral neuronal equivalents (PNEs). Using molecular and immunohistochemical 39 
techniques, together with Ca2+ microfluorimetry and whole cell patch clamping, we 40 
investigated roles for nerve growth factor (NGF) and the viral mimic Poly I:C in TRPA1 41 
activation. 42 
PNEs exhibited morphological, molecular and functional characteristics of sensory neurons 43 
and expressed functional TRPA1 channels. PNE treatment with NGF for 20 minutes 44 
generated significantly larger inward and outward currents compared to untreated PNEs in 45 
response to the TRPA1 agonist, cinnamaldehyde (p<0.05). PNE treatment with Poly I:C 46 
caused similar transient heightened responses to TRPA1 activation compared to untreated 47 
cells. 48 
Using the PNE neuronal model we observed both NGF and Poly I:C mediated sensory 49 
neuronal hyper-responsiveness, representing potential neuro-inflammatory mechanisms 50 
associated with heightened nociceptive responses recognised in cough hypersensitivity 51 
syndrome. 52 
53 
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 54 
Take home message 55 
Development of a novel human adult stem cell neuronal model to investigate neural hyper-56 
responsiveness in cough  57 
 58 
  59 
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INTRODUCTION 60 
Airway sensory nerves control cough and represent a means by which the lung clears 61 
secretions and protects itself against inhaled foreign bodies and irritants[1]. In conditions 62 
such as asthma and chronic cough this neural reflex becomes hyper-responsive causing 63 
troublesome bouts of cough typically triggered by low level physical and chemical stimuli[2, 64 
3]. These abnormal sensory responses often worsen during respiratory viral infections and 65 
while the effects of virus on airway epithelial and immune cells has been extensively studied 66 
little is known regarding the mechanisms responsible for airway neural hyper-67 
responsiveness[4-6]. Although the symptoms associated with airway hyper-responsiveness 68 
are what disturb patients most about their condition, there are no current treatments that 69 
adequately alleviate and ‘reset’ this state[7]. Potential therapeutic targets include the transient 70 
receptor potential (TRP) cation channels which are responsible for sensing chemical and 71 
physical stimuli and are expressed on many cell types including airway sensory nerves[8]. 72 
We have previously shown that human rhinovirus upregulates expression of TRP ankyrin 1 73 
(TRPA1) and TRP vanilloid 1 (TRPV1) channels in a neuronally differentiated immortalized 74 
human neuroblastoma cell line[9], however the mechanisms involved in nerve hyper-75 
responsiveness remain to be investigated. 76 
A number of neuroactive molecules are released into the airway following respiratory viral 77 
infection including nerve growth factor (NGF) which alters TRP channel function[10] and 78 
may be important in regulating airway sensory nerve responsiveness. In addition, sensory 79 
neurons are known to express Toll-like receptors (TLRs) which play a key role in host 80 
defence during microbial infection[11]. Toll-like receptor 3 (TLR 3) is of particular interest 81 
as it responds to viral double-stranded RNA (dsRNA), a by-product of replicating viruses 82 
including rhinovirus[12] and represents a potential route through which viral infection may 83 
induce cough reflex hyper-responsiveness. 84 
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Investigating TRP channel expression and regulation in human sensory neurons is 85 
challenging because the cell bodies of peripheral neurons are housed in neuronal ganglia 86 
which are not accessible by biopsy. Although TRP channel studies have been conducted in 87 
animal models[13-15] there are recognised interspecies differences in TRP function and 88 
expression[16-18]. Furthermore, in light of EU legislation for the protection of animals for 89 
scientific purposes there is an urgent need for development of a new generation of in vitro 90 
models based on human biology[19]. Thus, a human neuronal model could complement or 91 
potentially replace some animal models currently used in respiratory research and provide 92 
data that is relevant to human physiology.  93 
Dental pulp tissue derives from migrating neural crest cells during development[20,21] and is 94 
a source of multipotential stem/progenitor cells. The propensity for human dental pulp stem 95 
cells (hDPSCs) to differentiate towards a neuronal phenotype, previously termed peripheral 96 
neuronal equivalents (PNEs), has been reported[22-24] and is likely to be explained by their 97 
neural crest origin. Neural crest stem cells are the main contributors to the development of 98 
peripheral nerve fibres, including those of the trigeminal ganglion of the trigeminal nerve[25, 99 
26] and jugular ganglion of the vagus nerve[27]. Jugular ganglion C-fibres terminate within 100 
the extrapulmonary airways and respond directly to tussive stimuli such as capsaicin and 101 
bradykinin, express neuropeptides and tachykinins, and are thus considered important in 102 
nociceptive airway responses such as cough. Here we describe the development of a 103 
functional human in vitro neuronal model differentiated from hDPSCs, suitable for studying 104 
the role of neuroinflammatory factors in TRPA1 channel-mediated neuronal hyper-105 
responsiveness.  106 
Methods 107 
Full details are available in the online supplement. 108 
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 109 
Cell culture and hDPSC enrichment 110 
Human dental pulp cells were harvested from immature permanent third molar teeth in 111 
accordance with French ethics legislation[28] and maintained in minimal essential medium-112 
alpha (MEM-alpha) supplemented with 10% fetal bovine serum (FBS), 100 UI/mL penicillin 113 
and 100 µg/mL streptomycin, L-glutamine and 200 µM ascorbic acid. hDPSCs were enriched 114 
in dental pulp cell cultures by preferential adhesion to fibronectin (10 µg/mL overnight at 115 
4°C) coated 6-well plates and incubated at 37°C for 20 minutes. Non-adherent cells were 116 
discarded. hDPSCs were maintained on fibronectin for 2 days in MEM-alpha. 117 
 118 
Neural Induction 119 
hDPSCs were harvested from fibronectin-coated plates using trypsin and seeded onto 120 
plastic/glassware coated with poly-l-ornithine (0.01%) and laminin (5 µg/ml) and  incubated 121 
with neurobasal A supplemented with B27, glutaMAX, human basic fibroblast growth factor 122 
(40 ng/mL) and  epithelial growth factor (40 ng/ml) for 7 days. 123 
 124 
Immunofluorescence 125 
PNEs were differentiated from hDPSCs as described above on circular coverslips (16 mm, 126 
thickness 1). Cells were washed in phosphate buffered saline (PBS) and fixed by submerging 127 
in ice cold acetone for 8 minutes then air dried. Cells were washed in PBS and blocked for 128 
non-specific binding by incubation with 10% normal goat serum. 129 
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Cells were treated with specific primary antibody (Table S1; in 10% goat serum) overnight at 130 
4°C. Appropriate anti-species Alexa Fluor secondary antibody conjugates were diluted in 131 
PBS containing 0.1% Triton X 100 and applied to cells for 1h at room temperature. Samples 132 
were mounted using ProLong Gold with DAPI and viewed using a fluorescent microscope.  133 
 134 
qRT-PCR  135 
Neural induction of hDPSCs towards PNEs was achieved as outlined above except that cells 136 
were grown in 96 well plates. Total RNA was harvested using the PicoPure RNA isolation kit 137 
and quantified using a Take3 plate and plate reader. RNA samples were reverse transcribed 138 
using the SuperScript VILO cDNA synthesis kit according to the manufacturer’s instructions. 139 
qPCR reactions were set up using TaqMan universal mastermix with UNG according to the 140 
manufacturer’s instructions using predesigned Taqman primers (Table S2, S3). qPCR was 141 
carried out using the Stratagene PCR instrument and analysed using Mx3005P software.  142 
 143 
Whole Cell Patch Clamp 144 
PNEs were differentiated as described on coverslips (thickness 0). Whole cell currents were 145 
recorded using borosilicate patch pipettes (2 – 5 MΩ resistance), an Axopatch 200B amplifier 146 
and pClamp9 software.  147 
To measure voltage-gated Na+ channel activity, CsCl bath (150 mM NaCl, 6 mM CsCl, 1 148 
mM MgCl2, 1.5 mM CaCl2, 5 mM glucose and 10 mM HEPES in dH2O. pH altered to 7.4 149 
using Tris) and pipette (120 mM CsCl, 1 mM MgCl2, 4 mM Na2ATP, 10 mM BAPTA and 150 
10 mM HEPES in dH2O. pH altered to 7.2 using Tris) solutions were used. 1 µM 151 
tetrodotoxin (TTX) was made up in CsCl bath solution. Experiments were carried out at room 152 
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temperature. The holding potential was -120 mV. Current-voltage (I-V) relationships were 153 
measured using a voltage step protocol. 154 
TRP channel activity was recorded using a CsCl bath solution and a Cs-aspartate pipette 155 
solution (100 mM CsOH.2H2O, 100 mM aspartic acid, 20 mM CsCl, 1 mM MgCl2, 4 mM 156 
Na2ATP, 0.08 mM CaCl2, 10 mM BAPTA and 10 mM HEPES in dH2O. pH altered to 7.2 157 
using Tris). 100 µM cinnamaldehyde, 10 µM HC030031, 10 µM capsaicin and 20 µM 158 
capsazepine were made up in CsCl bath solution. Experiments were carried out at 37°C. The 159 
holding potential was 0 mV throughout. I-V relationships were recorded using a voltage ramp 160 
protocol. All data were analysed using Clampfit9 software. 161 
 162 
Microfluorimetric Calcium Imaging  163 
For microfluorimetric calcium imaging PNEs were differentiated as described on coverslips 164 
(thickness 0). PNEs were loaded with Fura-2AM (5 µM) for 40 minutes at 37°C, placed into 165 
a recording chamber mounted on the stage of an inverted microscope and superfused with 166 
hanks (140 mM NaCl, 5 mM KCl, 2 mM CaCl2.2H2O, 1 mM MgCl2, 10 mM HEPES free 167 
acid and 5 mM glucose in dH2O. pH altered to 7.4 using NaOH). All solutions were kept at a 168 
37°C using a water bath and perfusion system. [Ca2+]i was measured (details in online 169 
supplement) and TRP channel activity was observed as changes in [Ca2+]i following 170 
stimulation with 10 µM capsaicin and 10 µM capsazepine diluted in Hanks. 171 
 172 
Confocal Ca2+ imaging 173 
PNEs were loaded with 0.4µM fluo-4/AM for 6 minutes at room temperature and imaged 174 
using an iXon887 EMCCD camera (Andor Technology, Belfast) coupled to a Nipkow 175 
Page 11 of 72 European Respiratory Journal
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
  10 
 
spinning disk confocal head (CSU22, Yokogawa, Japan). A krypton-argon laser (Melles 176 
Griot UK) at 488 nm was used to excite the fluo-4, and the emitted light was detected at 177 
wavelengths >510 nm. Experiments were performed using a x60 objective (Olympus) and 178 
images were acquired at 15 frames per second. Background fluorescence from the camera, 179 
obtained using a null frame, was subtracted from each frame to obtain ‘F’. F0 was determined 180 
as the minimum fluorescence under control conditions. The pseudo line-scan image and 181 
corresponding intensity profile plot (Figs 2D,E) were obtained using Image J software (NIH). 182 
∆F/F0 refers to the measurement of the change in Ca2+ levels from basal to peak. 183 
 184 
ELISA 185 
PNEs were differentiated in 96 well plates. Supernatants were collected following treatments 186 
(as outlined below) and IL8 and IL6 levels were measured using human IL8 and IL6 DuoSet 187 
ELISA kits (R&D) according to the manufacturer’s instructions. 188 
 189 
Treatment of PNEs 190 
PNEs were treated with pro-inflammatory cytokines (nerve growth factor (NGF; 100 ng/ml); 191 
interleukin 1β (IL1β; 5 ng/ml); tumour necrosis factor alpha (TNFα; 10 ng/ml)) and Poly I:C 192 
(2 µg/ml) for 20 minutes, 6h or 24h(Table S4). Control cells were incubated with medium 193 
alone.  194 
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Results 195 
Enriched hDPSCs undergo neuronal differentiation to become functional PNEs 196 
hDPSCs expressed the neural crest protein markers, P75, AP2α and HNK1 (Fig. S1) and 197 
displayed a fibroblastic morphology consisting of splayed multipolar elongations (Fig. 1A). 198 
Following 7 days neuronal differentiation, cells acquired a typical bipolar neuronal 199 
morphology with a centrally located swollen cell body and axon-like projections (Fig. 1B). 200 
Immunofluorescence confirmed a phenotype change from hDPSC to PNE during 201 
differentiation, manifest by loss of expression of the fibroblast marker FSP (Fig 1C, D) and 202 
gain of specific mature neuronal markers PGP9.5 (Fig. 1E, F) and synaptophysin (Fig. 1G, 203 
H). PNEs also expressed the neuropeptides substance P and CGRP, consistent with a sensory 204 
neuronal phenotype (Fig. S2). 205 
Using whole cell patch clamping the neuronal phenotype of PNEs was further confirmed by 206 
demonstrating functional voltage-gated Na+ (NaV) channels. Using Cs-based bath and pipette 207 
solutions to block outward K+ currents, a family of rapidly inactivating inward currents were 208 
consistently generated when a series of 500 ms depolarising voltage steps were applied in 5 209 
mV increments from an initial holding potential of -120 mV (Fig. 1I) to a final test potential 210 
of 55 mV. Currents were completely inhibited by the Na+ channel inhibitor, TTX (1 µM) 211 
(Fig. 1J). Currents, normalised against cell capacitance, were plotted to show the I-V 212 
relationship (Fig. 1K).  213 
Since TRPV1 has long been associated with a neuronal phenotype, its gene and protein 214 
expression in PNEs was determined by qPCR (Table S5) and immunofluorescene (Fig 1L). 215 
To confirm TRPV1 functionality in PNEs, whole cell patch clamping was performed using 216 
Cs+-based bath and pipette solutions. Using a voltage ramp protocol, significant increases in 217 
both inward and outward currents were observed following application of the TRPV1 agonist 218 
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capsaicin (10 µM), which were significantly inhibited by capsazepine (20 µM; Fig. 1M, N). 219 
Vehicle only controls were unresponsive (Fig S3).  To further confirm the suitability of PNEs 220 
for functional studies, microfluorimetric [Ca2+]i imaging was performed for TRPV1 activity. 221 
Fura-loaded PNEs were shown to demonstrate spontaneous activity (Fig. S4), a characteristic 222 
of functional neurons, and upon capsaicin application an instantaneous increase in PNE 223 
[Ca2+]i was observed (Fig. S5A), with [Ca2+]i levels falling immediately afterwards. In the 224 
presence of the TRPV1 antagonist, capsazepine, PNE [Ca2+]i did not increase above basal 225 
levels (Fig. S5B). The change in ratio with capsaicin in the absence and presence of 226 
capsazepine was graphed for statistical analysis (Fig. S5C). 227 
 228 
PNEs express functional TRPA1 229 
Having established the neuronal phenotype of PNEs (Fig. 1) their suitability for studying 230 
TRPA1 channels was investigated. TRPA1 gene expression was confirmed by qPCR (Table 231 
S5) along with protein expression by immunofluorescence (Fig. 2A). To study the functional 232 
TRPA1 on PNEs, whole cell patch clamp experiments were performed using Cs+-based bath 233 
and pipette solutions. Using a voltage ramp protocol, significant increases in both inward and 234 
outward currents were observed in PNEs following application of  cinnamaldehyde (100 µM) 235 
which were blocked by HC030031 (10 µM; Fig 2B,C). Vehicle only controls were 236 
unresponsive (Fig S3).  To further confirm the suitability of PNEs for functional TRPA1 237 
studies we examined the effect of cinnamaldehyde (100 µM) on Ca2+ levels in single PNEs 238 
using confocal Ca2+ imaging. Cinnamaldehyde induced robust rises in [Ca2+]i that were 239 
reversibly inhibited by subsequent HC030031 application (see representative Figs. 2D,E and 240 
summary plot in Fig. 2F, n=9). Cinnamaldehyde responses were demonstrated to be 241 
concentration dependent (Figs 2G&H), with an EC50 of 54 µM. Using microfluorimetric 242 
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[Ca2+]i imaging fura-loaded PNEs showed spontaneous activity (Fig. S4), and upon 243 
application of cinnamaldehyde an instantaneous increase in PNE [Ca2+]i was observed (Fig. 244 
S6A), followed by falling [Ca2+]i levels immediately afterwards. In the presenceHC030031, 245 
PNE [Ca2+]i did not increase above basal levels (Fig. S6B). The mean change in ratio was 246 
graphed for statistical analysis (Fig. S6C). 247 
 248 
NGF induces TRPA1 hyper-responsiveness on PNEs 249 
NGF is known to induce hyper-responsiveness in sensory neurons [10, 29, 30] and is 250 
therefore a neuropathic cytokine worthy of investigating in this in vitro model. PNEs treated 251 
with NGF for 20 minutes immediately prior to patch clamp experiments generated 252 
significantly (p < 0.05) larger inward and outward currents when stimulated with 253 
cinnamaldehyde (Fig. 3A), demonstrating that PNE TRPA1 channels hyper-responsiveness in 254 
the presence of NGF. This hyper-responsive state was not sustained as PNEs treated for 24h 255 
did not generate the larger currents observed previously (Fig. 3A). 256 
To investigate whether TRPA1 gene expression was altered following NGF treatment we 257 
undertook qRT-PCR on PNEs incubated with NGF for 6h and 24h. No significant changes in 258 
TRPA1 gene expression were observed (Fig. 3B). To determine whether this was an NGF-259 
specific effect, we treated PNEs with the proinflammatory cytokines TNFα (10 ng/ml) and 260 
IL1β (5 ng/ml), and observed no significant change in TRPA1 gene expression (Fig. S7).  261 
We also investigated whether similar effects in response to NGF treatment were observed in 262 
PNEs stimulated with capsaicin. No significant changes in capsaicin-induced currents were 263 
seen between untreated and NGF treated cells (Fig. S8A). Similarly, no changes were 264 
determined in TRPV1 gene expression following NGF treatment (Fig. S8B). 265 
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The viral mimetic Poly I:C induces IL8 release and TRPA1 hyper-responsiveness in PNEs 266 
Poly I:C was employed to demonstrate the usefulness of the model to investigate the effects 267 
of viral infections on sensory neurons. Cell supernatants from PNEs incubated with Poly I:C 268 
were analysed for IL8 and IL6. Supernatants from control cells, and those incubated with 269 
Poly I:C for 6h showed no significant change in IL8 levels, and no detectable IL6 in controls 270 
(Fig. 4A, B). However, supernatants from cells incubated with Poly I:C for 24h had 271 
significantly higher levels of IL8 (2140.8 pg/ml) and IL6 (246.5 pg/ml) (Fig. 4A, B). 272 
Additional concentration and time-dependent effects of Poly I:C on IL8 levels are reported in 273 
Fig S9.  274 
Poly I:C also induced TRPA1 hyper-responsiveness in PNEs. Treatment of PNEs with Poly 275 
I:C for 20 minutes immediately prior to patch clamping generated significantly larger inward 276 
and outward currents in response to cinnamaldehyde, compared with untreated PNEs (Fig. 277 
4C). PNEs incubated with Poly I:C for 24h were not readily amenable to patch-clamp 278 
recording, suggesting changes had occurred in the plasma membrane.  No significant changes 279 
were observed in TRPA1 gene expression following 6h or 24h Poly I:C treatments (Fig. 4D). 280 
 281 
Discussion 282 
In this study we successfully differentiated stem cells from human dental pulp towards PNEs 283 
which have morphological, molecular and functional characteristics of sensory neurons. We 284 
observed TRPA1 channel hyper-responsiveness following stimulation with both NGF and the 285 
viral mimic Poly I:C. Responses were rapid in onset, and independent of TRPA1 gene 286 
expression. Taken together our data suggest that PNEs represent a novel, species-specific in 287 
vitro model for the investigation of TRPA1 channel function and regulation on human 288 
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sensory neurons.  We believe this model has potential to provide insight into the potential 289 
mechanisms involved in cough hypersensitivity. 290 
 291 
An important refinement in our approach was the enrichment of hDPSCs from dental pulp 292 
cultures using differential fibronectin adhesion, allowing a phenotype switch from hDPSC to 293 
PNE in 7 days compared with 21 days previously reported using dental pulp cell cultures 294 
[22]. Functional neuronal activity in differentiated cells as described herein, should be 295 
considered a prerequisite for neuronal characterisation, particularly in view of the finding that 296 
voltage-dependent sodium channels are not present on hDPSCs[31].   297 
To provide evidence for the suitability of PNEs as an in vitro model for the study of 298 
inflammatory TRP channel regulation we investigated the effect of the neurotrophic cytokine 299 
NGF. Levels of NGF are elevated in the airways of asthmatics[32] and in children with 300 
influenza infection airway NGF levels are increased and correlate with disease severity and 301 
cough duration[33] We observed that NGF rapidly induced increased TRPA1 activation 302 
consistent with that reported previously in primary cultures of mouse sensory neurons[28]. 303 
Such rapid effects are likely to be due to activation of intracellular cell signalling pathways 304 
resulting in phosphorylation of the TRP channel with subsequent channel hyper-305 
responsiveness[9]. Our data suggest NGF can rapidly induce TRPA1 channel hyper-306 
responsiveness, supporting a role for transcription-independent mechanisms in regulating 307 
TRP responses[10]. Interestingly, we did not see increased responses to capsaicin in NGF-308 
treated cells, previously reported in a guinea pig model in vivo[34]. This disparity could serve 309 
to highlight differences between animal and human tissues and may add clinical relevance to 310 
the PNE model. It is also notable that positive preclinical data in animal models of the 311 
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TRPV1 antagonist XEN-D0501 sharply contrasts the lack of efficacy reported in a placebo 312 
controlled trial in chronic cough[35].  313 
Following PNE treatment with the viral mimic Poly I:C significant increases in IL8 and IL6 314 
secretion and increased currents in response to cinnamaldehyde, were observed compared to 315 
untreated PNEs. This is the first report to suggest a functional relationship between TRPA1 316 
and Poly I:C. It is known that the viral mimetic Poly I:C mimics the pathogen associated 317 
molecular pattern (PAMP) dsRNA, and activates three pattern recognition receptors (PRRs) 318 
TLR3, retinoic acid-inducible gene 1 (RIG-I) and melanoma differentiation-associated 319 
protein 5 (MDA5)[36]. Functional interactionsTRPA1 and Poly I:C could therefore be 320 
mediated via one or more of these receptors.  321 
In conclusion, PNEs represent a novel species-specific in vitro model suitable for the study of 322 
TRP channel function and regulation on human sensory neurons which is in line with current 323 
EU and UK directives to replace, reduce and refine the use of animals in research[19]. Using 324 
this model we have demonstrated that NGF and the viral mimic Poly I:C directly and rapidly 325 
induce a TRP channel hyper-responsiveness on the cell membranes of human sensory nerves 326 
representing a possible neuro-inflammatory process responsible for cough reflex hyper-327 
responsiveness. We have been careful to distinguish our experimental findings of neuronal 328 
hyper-responsiveness from neuronal hypersensitivity. Under experimental neuro-329 
inflammatory conditions we observed an increased neural response for a given stimulus 330 
which may have a clinical parallel in the form of ‘hypertussia’ observed in patients with 331 
Cough Hypersensitivity Syndrome (CHS) [37]. We have yet to determine if our PNE model 332 
can be rendered ‘hypersensitive’ to low level stimulation. CHS is a disorder gaining 333 
increasing recognition amongst respiratory, allergy, gastroenterology, speech/voice and 334 
otolaryngology healthcare professionals[37].  There is a need to improve our understanding 335 
of the neurobiology of this condition and we believe the novel techniques we report in this 336 
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manuscript and the clinical relevance of our experimental findings will be of interest to those 337 
working in this field.   338 
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FIGURE LEGENDS 446 
Figure 1: hDPSCs undergo both morphological and phenotype changes during neuronal 447 
differentiation to become functional PNEs. hDPSCs have a fibroblastic morphology 448 
consisting of splayed multipolar elongations (A). Following neuronal differentiation the cells 449 
lose this shape and take on a typical bipolar neuronal morphology consisting of a swollen cell 450 
body and axon-like projections (B). Undifferentiated hDPSCs express the fibroblast marker 451 
FSP (C). This FSP expression is lost during neuronal differentiation and is no longer 452 
expressed in PNEs (D). Prior to neuronal differentiation, hDPSCs do not express the specific 453 
neuronal markers PGP9.5 (E) or synaptophysin (G), which are present in PNE cultures (F and 454 
H respectively). PNEs exhibit voltage-activated Na+ currents following 7 days differentiation. 455 
Family of inward currents recorded from a PNE following a series of 500 ms depolarising 456 
voltage steps from an initial holding potential -120 mV to 55 mV in 5 mV increments (I). 457 
This response, in the same cells, was completely inhibited in the presence of TTX (1 µM; J). 458 
I-V relationships in the absence and presence of TTX normalised against cell capacitance (K; 459 
n=7; mean cell capacitance: 38 pF, SEM: 2.85 (measured using pClamp software)). Bars 460 
represent SEM, ** P < 0.01, *** P < 0.001. TRPV1 expression in PNEs was shown by 461 
immunofluorescence (L). Whole cell patch clamping recording was carried out on PNEs to 462 
investigate the functional expression of TRPV1 channels. Addition of the TRPV1 agonist 463 
capsaicin during voltage ramp protocols increased both inward and outward membrane 464 
currents. This response was inhibited in the presence of the TRPV1 antagonist capsazepine 465 
(M). Peak currents were measured at -80 mV and 80 mV for statistical analysis (N).  466 
 467 
Figure 2: The presence of TRPA1 channel proteins in PNEs was confirmed using 468 
immunofluorescence (A). Whole cell patch clamping recording was carried out on PNEs to 469 
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investigate the functional expression of TRPA1 channels. Addition of the TRPA1 agonist 470 
cinnamaldehyde during voltage ramp protocols increased both inward and outward 471 
membrane currents. This response was inhibited in the presence of the TRPA1 antagonist 472 
HC030031 (B). Peak currents were measured at -80 mV and 80 mV for statistical analysis 473 
(C). Application of cinnamaldehyde to isolated PNEs induced robust rises in [Ca2+]i that were 474 
reversibly inhibited by subsequent application of HC030031 (D,E). In 9 cells the mean 475 
amplitude of cinnamaldehyde responses was significantly reduced from 1.96 ∆F/F0 under 476 
control conditions to 0.02 ∆F/F0 in the presence of HC030031, p<0.01, paired Student’s t test 477 
(F). Error bars represent SEM. Cinnamaldehyde-induced elevations of [Ca2+]i were 478 
concentration dependent and the mean EC50 value for this effect was 54 µM (95% confidence 479 
intervals 38-79 µM, n=4, Figs 2G&H, respectively).  480 
 481 
Figure 3: PNE TRPA1 channels become hyper-responsive following 20 minutes incubation 482 
with the pro-inflammatory mediator NGF (100 ng/ml) but this effect was not apparent in 483 
PNEs incubated with NGF for 24hr they did not show heightened responses to 484 
cinnamaldehyde (100 µM; A). This hyper-responsiveness also appears to be independent of 485 
gene expression as no significant changes in TRPA1 gene expression in PNEs were observed 486 
following 6h and 24h NGF (100 ng/ml) treatments (B).  487 
 488 
Figure 4: Poly I:C induces IL8 and IL6 secretion in PNE cultures. Supernatants taken from 489 
PNEs incubated with Poly I:C (2 µg/ml) for 24h showed increased IL8 and IL6 levels than 490 
those taken from untreated PNEs or PNEs incubated with Poly I:C for only 6h (A and B 491 
respectively). PNE TRPA1 channels become hyper-responsive following 20 minutes 492 
incubation with the viral mimetic Poly I:C (2 µg/ml). PNEs treated with Poly I:C 493 
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demonstrated heightened responses to the TRPA1 agonist cinnamaldehyde (100 µM) 494 
compared to those seen in untreated PNEs (C). This hyper-responsiveness appears to be 495 
independent of gene expression as no significant changes in TRPA1 gene expression in PNEs 496 
were observed following 6h and 24h Poly I:C treatments (D). Bars represent SEM, * P < 497 
0.05, ** P < 0.01, *** P<0.005. 498 
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ABSTRACT 31 
The cough reflex becomes hyper-responsive in acute and chronic respiratory diseases, but 32 
understanding the underlying mechanism is hampered by difficulty accessing human tissue 33 
containing both nerve endings and neuronal cell bodies. We refined an adult stem-cell 34 
sensory neuronal model to overcome the limited availability of human neurones and applied 35 
the model to study transient receptor potential ankyrin 1 (TRPA1) channel expression and 36 
activation.  37 
Human dental pulp stem cells (hDPSCs) were differentiated towards a neuronal phenotype, 38 
termed peripheral neuronal equivalents (PNEs). Using molecular and immunohistochemical 39 
techniques, together with Ca
2+
 microfluorimetry and whole cell patch clamping, we 40 
investigated roles for nerve growth factor (NGF) and the viral mimic Poly I:C in TRPA1 41 
activation.  42 
PNEs exhibited morphological, molecular and functional characteristics of sensory neurons 43 
and expressed functional TRPA1 channels. PNE treatment with NGF for 20 minutes 44 
generated significantly larger inward and outward currents compared to untreated PNEs in 45 
response to the TRPA1 agonist, cinnamaldehyde (p<0.05). PNE treatment with Poly I:C 46 
caused similar transient heightened responses to TRPA1 activation compared to untreated 47 
cells. 48 
Using the PNE neuronal model we observed both NGF and Poly I:C mediated sensory 49 
neuronal hyper-responsiveness, representing potential neuro-inflammatory mechanisms 50 
associated with heightened nociceptive responses recognised in cough hypersensitivity 51 
syndrome.  52 
  53 
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 54 
Take home message 55 
Development of a novel human adult stem cell neuronal model to investigate neural hyper-56 
responsiveness in cough  57 
 58 
  59 
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INTRODUCTION 60 
Airway sensory nerves control cough and represent a means by which the lung clears 61 
secretions and protects itself against inhaled foreign bodies and irritants[1]. In conditions 62 
such as asthma and chronic cough this neural reflex becomes hyper-responsive causing 63 
troublesome bouts of cough typically triggered by low level physical and chemical stimuli[2, 64 
3]. These abnormal sensory responses often worsen during respiratory viral infections and 65 
while the effects of virus on airway epithelial and immune cells has been extensively studied 66 
little is known regarding the mechanisms responsible for airway neural hyper-67 
responsiveness[4-6]. Although the symptoms associated with airway hyper-responsiveness 68 
are what disturb patients most about their condition, there are no current treatments that 69 
adequately alleviate and ‘reset’ this state[7]. Potential therapeutic targets include the transient 70 
receptor potential (TRP) cation channels which are responsible for sensing chemical and 71 
physical stimuli and are expressed on many cell types including airway sensory nerves[8]. 72 
We have previously shown that human rhinovirus upregulates expression of TRP ankyrin 1 73 
(TRPA1) and TRP vanilloid 1 (TRPV1) channels in a neuronally differentiated immortalized 74 
human neuroblastoma cell line[9], however the mechanisms involved in nerve hyper-75 
responsiveness remain to be investigated. 76 
A number of neuroactive molecules are released into the airway following respiratory viral 77 
infection including nerve growth factor (NGF) which alters TRP channel function[10] and 78 
may be important in regulating airway sensory nerve responsiveness. In addition, sensory 79 
neurons are known to express Toll-like receptors (TLRs) which play a key role in host 80 
defence during microbial infection[11]. Toll-like receptor 3 (TLR 3) is of particular interest 81 
as it responds to viral double-stranded RNA (dsRNA), a by-product of replicating viruses 82 
including rhinovirus[12] and represents a potential route through which viral infection may 83 
induce cough reflex hyper-responsiveness. 84 
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Investigating TRP channel expression and regulation in human sensory neurons is 85 
challenging because the cell bodies of peripheral neurons are housed in neuronal ganglia 86 
which are not accessible by biopsy. Although TRP channel studies have been conducted in 87 
animal models[13-15] there are recognised interspecies differences in TRP function and 88 
expression[16-18]. Furthermore, in light of EU legislation for the protection of animals for 89 
scientific purposes there is an urgent need for development of a new generation of in vitro 90 
models based on human biology[19]. Thus, a human neuronal model could complement or 91 
potentially replace some animal models currently used in respiratory research and provide 92 
data that is relevant to human physiology.  93 
Dental pulp tissue derives from migrating neural crest cells during development[20,21] and is 94 
a source of multipotential stem/progenitor cells. The propensity for human dental pulp stem 95 
cells (hDPSCs) to differentiate towards a neuronal phenotype, previously termed peripheral 96 
neuronal equivalents (PNEs), has been reported[22-24] and is likely to be explained by their 97 
neural crest origin. Neural crest stem cells are the main contributors to the development of 98 
peripheral nerve fibres, including those of the trigeminal ganglion of the trigeminal nerve[25, 99 
26] and jugular ganglion of the vagus nerve[27]. Jugular ganglion C-fibres terminate within 100 
the extrapulmonary airways and respond directly to tussive stimuli such as capsaicin and 101 
bradykinin, express neuropeptides and tachykinins, and are thus considered important in 102 
nociceptive airway responses such as cough. Here we describe the development of a 103 
functional human in vitro neuronal model differentiated from hDPSCs, suitable for studying 104 
the role of neuroinflammatory factors in TRPA1 channel-mediated neuronal hyper-105 
responsiveness.  106 
Methods 107 
Full details are available in the online supplement. 108 
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 109 
Cell culture and hDPSC enrichment 110 
Human dental pulp cells were harvested from immature permanent third molar teeth in 111 
accordance with French ethics legislation[28] and maintained in minimal essential medium-112 
alpha (MEM-alpha) supplemented with 10% fetal bovine serum (FBS), 100 UI/mL penicillin 113 
and 100 µg/mL streptomycin, L-glutamine and 200 µM ascorbic acid. hDPSCs were enriched 114 
in dental pulp cell cultures by preferential adhesion to fibronectin (10 µg/mL overnight at 115 
4°C) coated 6-well plates and incubated at 37°C for 20 minutes. Non-adherent cells were 116 
discarded. hDPSCs were maintained on fibronectin for 2 days in MEM-alpha. 117 
 118 
Neural Induction 119 
hDPSCs were harvested from fibronectin-coated plates using trypsin and seeded onto 120 
plastic/glassware coated with poly-l-ornithine (0.01%) and laminin (5 µg/ml) and  incubated 121 
with neurobasal A supplemented with B27, glutaMAX, human basic fibroblast growth factor 122 
(40 ng/mL) and  epithelial growth factor (40 ng/ml) for 7 days. 123 
 124 
Immunofluorescence 125 
PNEs were differentiated from hDPSCs as described above on circular coverslips (16 mm, 126 
thickness 1). Cells were washed in phosphate buffered saline (PBS) and fixed by submerging 127 
in ice cold acetone for 8 minutes then air dried. Cells were washed in PBS and blocked for 128 
non-specific binding by incubation with 10% normal goat serum. 129 
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Cells were treated with specific primary antibody (Table S1; in 10% goat serum) overnight at 130 
4°C. Appropriate anti-species Alexa Fluor secondary antibody conjugates were diluted in 131 
PBS containing 0.1% Triton X 100 and applied to cells for 1h at room temperature. Samples 132 
were mounted using ProLong Gold with DAPI and viewed using a fluorescent microscope.  133 
 134 
qRT-PCR  135 
Neural induction of hDPSCs towards PNEs was achieved as outlined above except that cells 136 
were grown in 96 well plates. Total RNA was harvested using the PicoPure RNA isolation kit 137 
and quantified using a Take3 plate and plate reader. RNA samples were reverse transcribed 138 
using the SuperScript VILO cDNA synthesis kit according to the manufacturer’s instructions. 139 
qPCR reactions were set up using TaqMan universal mastermix with UNG according to the 140 
manufacturer’s instructions using predesigned Taqman primers (Table S2, S3). qPCR was 141 
carried out using the Stratagene PCR instrument and analysed using Mx3005P software.  142 
 143 
Whole Cell Patch Clamp 144 
PNEs were differentiated as described on coverslips (thickness 0). Whole cell currents were 145 
recorded using borosilicate patch pipettes (2 – 5 MΩ resistance), an Axopatch 200B amplifier 146 
and pClamp9 software.  147 
To measure voltage-gated Na+ channel activity, CsCl bath (150 mM NaCl, 6 mM CsCl, 1 148 
mM MgCl2, 1.5 mM CaCl2, 5 mM glucose and 10 mM HEPES in dH2O. pH altered to 7.4 149 
using Tris) and pipette (120 mM CsCl, 1 mM MgCl2, 4 mM Na2ATP, 10 mM BAPTA and 150 
10 mM HEPES in dH2O. pH altered to 7.2 using Tris) solutions were used. 1 µM 151 
tetrodotoxin (TTX) was made up in CsCl bath solution. Experiments were carried out at room 152 
Page 33 of 72 European Respiratory Journal
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
  9 
 
temperature. The holding potential was -120 mV. Current-voltage (I-V) relationships were 153 
measured using a voltage step protocol. 154 
TRP channel activity was recorded using a CsCl bath solution and a Cs-aspartate pipette 155 
solution (100 mM CsOH.2H2O, 100 mM aspartic acid, 20 mM CsCl, 1 mM MgCl2, 4 mM 156 
Na2ATP, 0.08 mM CaCl2, 10 mM BAPTA and 10 mM HEPES in dH2O. pH altered to 7.2 157 
using Tris). 100 µM cinnamaldehyde, 10 µM HC030031, 10 µM capsaicin and 20 µM 158 
capsazepine were made up in CsCl bath solution. Experiments were carried out at 37°C. The 159 
holding potential was 0 mV throughout. I-V relationships were recorded using a voltage ramp 160 
protocol. All data were analysed using Clampfit9 software. 161 
 162 
Microfluorimetric Calcium Imaging  163 
For microfluorimetric calcium imaging PNEs were differentiated as described on coverslips 164 
(thickness 0). PNEs were loaded with Fura-2AM (5 µM) for 40 minutes at 37°C, placed into 165 
a recording chamber mounted on the stage of an inverted microscope and superfused with 166 
hanks (140 mM NaCl, 5 mM KCl, 2 mM CaCl2.2H2O, 1 mM MgCl2, 10 mM HEPES free 167 
acid and 5 mM glucose in dH2O. pH altered to 7.4 using NaOH). All solutions were kept at a 168 
37°C using a water bath and perfusion system. [Ca2+]i was measured (details in online 169 
supplement) and TRP channel activity was observed as changes in [Ca2+]i following 170 
stimulation with 10 µM capsaicin and 10 µM capsazepine diluted in Hanks. 171 
 172 
Confocal Ca2+ imaging 173 
PNEs were loaded with 0.4µM fluo-4/AM for 6 minutes at room temperature and imaged 174 
using an iXon887 EMCCD camera (Andor Technology, Belfast) coupled to a Nipkow 175 
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spinning disk confocal head (CSU22, Yokogawa, Japan). A krypton-argon laser (Melles 176 
Griot UK) at 488 nm was used to excite the fluo-4, and the emitted light was detected at 177 
wavelengths >510 nm. Experiments were performed using a x60 objective (Olympus) and 178 
images were acquired at 15 frames per second. Background fluorescence from the camera, 179 
obtained using a null frame, was subtracted from each frame to obtain ‘F’. F0 was determined 180 
as the minimum fluorescence under control conditions. The pseudo line-scan image and 181 
corresponding intensity profile plot (Figs 2D,E) were obtained using Image J software (NIH). 182 
∆F/F0 refers to the measurement of the change in Ca2+ levels from basal to peak. 183 
 184 
ELISA 185 
PNEs were differentiated in 96 well plates. Supernatants were collected following treatments 186 
(as outlined below) and IL8 and IL6 levels were measured using human IL8 and IL6 DuoSet 187 
ELISA kits (R&D) according to the manufacturer’s instructions. 188 
 189 
Treatment of PNEs 190 
PNEs were treated with pro-inflammatory cytokines (nerve growth factor (NGF; 100 ng/ml); 191 
interleukin 1β (IL1β; 5 ng/ml); tumour necrosis factor alpha (TNFα; 10 ng/ml)) and Poly I:C 192 
(2 µg/ml) for 20 minutes, 6h or 24h(Table S4). Control cells were incubated with medium 193 
alone.  194 
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Results 195 
Enriched hDPSCs undergo neuronal differentiation to become functional PNEs 196 
hDPSCs expressed the neural crest protein markers, P75, AP2α and HNK1 (Fig. S1) and 197 
displayed a fibroblastic morphology consisting of splayed multipolar elongations (Fig. 1A). 198 
Following 7 days neuronal differentiation, cells acquired a typical bipolar neuronal 199 
morphology with a centrally located swollen cell body and axon-like projections (Fig. 1B). 200 
Immunofluorescence confirmed a phenotype change from hDPSC to PNE during 201 
differentiation, manifest by loss of expression of the fibroblast marker FSP (Fig 1C, D) and 202 
gain of specific mature neuronal markers PGP9.5 (Fig. 1E, F) and synaptophysin (Fig. 1G, 203 
H). PNEs also expressed the neuropeptides substance P and CGRP, consistent with a sensory 204 
neuronal phenotype (Fig. S2). 205 
Using whole cell patch clamping the neuronal phenotype of PNEs was further confirmed by 206 
demonstrating functional voltage-gated Na
+
 (NaV) channels. Using Cs-based bath and pipette 207 
solutions to block outward K+ currents, a family of rapidly inactivating inward currents were 208 
consistently generated when a series of 500 ms depolarising voltage steps were applied in 5 209 
mV increments from an initial holding potential of -120 mV (Fig. 1I) to a final test potential 210 
of 55 mV. Currents were completely inhibited by the Na+ channel inhibitor, TTX (1 µM) 211 
(Fig. 1J). Currents, normalised against cell capacitance, were plotted to show the I-V 212 
relationship (Fig. 1K).  213 
Since TRPV1 has long been associated with a neuronal phenotype, its gene and protein 214 
expression in PNEs was determined by qPCR (Table S5) and immunofluorescene (Fig 1L). 215 
To confirm TRPV1 functionality in PNEs, whole cell patch clamping was performed using 216 
Cs
+
-based bath and pipette solutions. Using a voltage ramp protocol, significant increases in 217 
both inward and outward currents were observed following application of the TRPV1 agonist 218 
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capsaicin (10 µM), which were significantly inhibited by capsazepine (20 µM; Fig. 1M, N). 219 
Vehicle only controls were unresponsive (Fig S3).  To further confirm the suitability of PNEs 220 
for functional studies, microfluorimetric [Ca2+]i imaging was performed for TRPV1 activity. 221 
Fura-loaded PNEs were shown to demonstrate spontaneous activity (Fig. S4), a characteristic 222 
of functional neurons, and upon capsaicin application an instantaneous increase in PNE 223 
[Ca
2+
]i was observed (Fig. S5A), with [Ca
2+
]i levels falling immediately afterwards. In the 224 
presence of the TRPV1 antagonist, capsazepine, PNE [Ca2+]i did not increase above basal 225 
levels (Fig. S5B). The change in ratio with capsaicin in the absence and presence of 226 
capsazepine was graphed for statistical analysis (Fig. S5C). 227 
 228 
PNEs express functional TRPA1 229 
Having established the neuronal phenotype of PNEs (Fig. 1) their suitability for studying 230 
TRPA1 channels was investigated. TRPA1 gene expression was confirmed by qPCR (Table 231 
S5) along with protein expression by immunofluorescence (Fig. 2A). To study the functional 232 
TRPA1 on PNEs, whole cell patch clamp experiments were performed using Cs+-based bath 233 
and pipette solutions. Using a voltage ramp protocol, significant increases in both inward and 234 
outward currents were observed in PNEs following application of  cinnamaldehyde (100 µM) 235 
which were blocked by HC030031 (10 µM; Fig 2B,C). Vehicle only controls were 236 
unresponsive (Fig S3).  To further confirm the suitability of PNEs for functional TRPA1 237 
studies we examined the effect of cinnamaldehyde (100 µM) on Ca
2+ 
levels in single PNEs 238 
using confocal Ca2+ imaging. Cinnamaldehyde induced robust rises in [Ca2+]i that were 239 
reversibly inhibited by subsequent HC030031 application (see representative Figs. 2D,E and 240 
summary plot in Fig. 2F, n=9). Cinnamaldehyde responses were demonstrated to be 241 
concentration dependent (Figs 2G&H), with an EC50 of 54 µM. Using microfluorimetric 242 
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[Ca2+]i imaging fura-loaded PNEs showed spontaneous activity (Fig. S4), and upon 243 
application of cinnamaldehyde an instantaneous increase in PNE [Ca
2+
]i was observed (Fig. 244 
S6A), followed by falling [Ca2+]i levels immediately afterwards. In the presenceHC030031, 245 
PNE [Ca
2+
]i did not increase above basal levels (Fig. S6B). The mean change in ratio was 246 
graphed for statistical analysis (Fig. S6C). 247 
 248 
NGF induces TRPA1 hyper-responsiveness on PNEs 249 
NGF is known to induce hyper-responsiveness in sensory neurons [10, 29, 30] and is 250 
therefore a neuropathic cytokine worthy of investigating in this in vitro model. PNEs treated 251 
with NGF for 20 minutes immediately prior to patch clamp experiments generated 252 
significantly (p < 0.05) larger inward and outward currents when stimulated with 253 
cinnamaldehyde (Fig. 3A), demonstrating that PNE TRPA1 channels hyper-responsiveness in 254 
the presence of NGF. This hyper-responsive state was not sustained as PNEs treated for 24h 255 
did not generate the larger currents observed previously (Fig. 3A). 256 
To investigate whether TRPA1 gene expression was altered following NGF treatment we 257 
undertook qRT-PCR on PNEs incubated with NGF for 6h and 24h. No significant changes in 258 
TRPA1 gene expression were observed (Fig. 3B). To determine whether this was an NGF-259 
specific effect, we treated PNEs with the proinflammatory cytokines TNFα (10 ng/ml) and 260 
IL1β (5 ng/ml), and observed no significant change in TRPA1 gene expression (Fig. S7).  261 
We also investigated whether similar effects in response to NGF treatment were observed in 262 
PNEs stimulated with capsaicin. No significant changes in capsaicin-induced currents were 263 
seen between untreated and NGF treated cells (Fig. S8A). Similarly, no changes were 264 
determined in TRPV1 gene expression following NGF treatment (Fig. S8B). 265 
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The viral mimetic Poly I:C induces IL8 release and TRPA1 hyper-responsiveness in PNEs 266 
Poly I:C was employed to demonstrate the usefulness of the model to investigate the effects 267 
of viral infections on sensory neurons. Cell supernatants from PNEs incubated with Poly I:C 268 
were analysed for IL8 and IL6. Supernatants from control cells, and those incubated with 269 
Poly I:C for 6h showed no significant change in IL8 levels, and no detectable IL6 in controls 270 
(Fig. 4A, B). However, supernatants from cells incubated with Poly I:C for 24h had 271 
significantly higher levels of IL8 (2140.8 pg/ml) and IL6 (246.5 pg/ml) (Fig. 4A, B). 272 
Additional concentration and time-dependent effects of Poly I:C on IL8 levels are reported in 273 
Fig S9.  274 
Poly I:C also induced TRPA1 hyper-responsiveness in PNEs. Treatment of PNEs with Poly 275 
I:C for 20 minutes immediately prior to patch clamping generated significantly larger inward 276 
and outward currents in response to cinnamaldehyde, compared with untreated PNEs (Fig. 277 
4C). PNEs incubated with Poly I:C for 24h were not readily amenable to patch-clamp 278 
recording, suggesting changes had occurred in the plasma membrane.  No significant changes 279 
were observed in TRPA1 gene expression following 6h or 24h Poly I:C treatments (Fig. 4D). 280 
 281 
Discussion 282 
In this study we successfully differentiated stem cells from human dental pulp towards PNEs 283 
which have morphological, molecular and functional characteristics of sensory neurons. We 284 
observed TRPA1 channel hyper-responsiveness following stimulation with both NGF and the 285 
viral mimic Poly I:C. Responses were rapid in onset, and independent of TRPA1 gene 286 
expression. Taken together our data suggest that PNEs represent a novel, species-specific in 287 
vitro model for the investigation of TRPA1 channel function and regulation on human 288 
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sensory neurons.  We believe this model has potential to provide insight into the potential 289 
mechanisms involved in cough hypersensitivity. 290 
 291 
An important refinement in our approach was the enrichment of hDPSCs from dental pulp 292 
cultures using differential fibronectin adhesion, allowing a phenotype switch from hDPSC to 293 
PNE in 7 days compared with 21 days previously reported using dental pulp cell cultures 294 
[22]. Functional neuronal activity in differentiated cells as described herein, should be 295 
considered a prerequisite for neuronal characterisation, particularly in view of the finding that 296 
voltage-dependent sodium channels are not present on hDPSCs[31].   297 
To provide evidence for the suitability of PNEs as an in vitro model for the study of 298 
inflammatory TRP channel regulation we investigated the effect of the neurotrophic cytokine 299 
NGF. Levels of NGF are elevated in the airways of asthmatics[32] and in children with 300 
influenza infection airway NGF levels are increased and correlate with disease severity and 301 
cough duration[33] We observed that NGF rapidly induced increased TRPA1 activation 302 
consistent with that reported previously in primary cultures of mouse sensory neurons[28]. 303 
Such rapid effects are likely to be due to activation of intracellular cell signalling pathways 304 
resulting in phosphorylation of the TRP channel with subsequent channel hyper-305 
responsiveness[9]. Our data suggest NGF can rapidly induce TRPA1 channel hyper-306 
responsiveness, supporting a role for transcription-independent mechanisms in regulating 307 
TRP responses[10]. Interestingly, we did not see increased responses to capsaicin in NGF-308 
treated cells, previously reported in a guinea pig model in vivo[34]. This disparity could serve 309 
to highlight differences between animal and human tissues and may add clinical relevance to 310 
the PNE model. It is also notable that positive preclinical data in animal models of the 311 
TRPV1 antagonist XEN-D0501 sharply contrasts the lack of efficacy reported in a placebo 312 
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controlled trial in chronic cough[35]. This disparity could serve to highlight differences 313 
between animal and human tissues.  314 
Following PNE treatment with the viral mimic Poly I:C significant increases in IL8 and IL6 315 
secretion and increased currents in response to cinnamaldehyde, were observed compared to 316 
untreated PNEs. This is the first report to suggest a functional relationship between TRPA1 317 
and Poly I:C. It is known that the viral mimetic Poly I:C mimics the pathogen associated 318 
molecular pattern (PAMP) dsRNA, and activates three pattern recognition receptors (PRRs) 319 
TLR3, retinoic acid-inducible gene 1 (RIG-I) and melanoma differentiation-associated 320 
protein 5 (MDA5)[3536]. Functional interactionsTRPA1 and Poly I:C could therefore be 321 
mediated via one or more of these receptors.  322 
In conclusion, PNEs represent a novel species-specific in vitro model suitable for the study of 323 
TRP channel function and regulation on human sensory neurons which is in line with current 324 
EU and UK directives to replace, reduce and refine the use of animals in research[19]. Using 325 
this model we have demonstrated that NGF and the viral mimic Poly I:C directly and rapidly 326 
induce a TRP channel hyper-responsiveness on the cell membranes of human sensory nerves 327 
representing a possible neuro-inflammatory process responsible for cough reflex hyper-328 
responsiveness. We have been careful to distinguish our experimental findings of neuronal 329 
hyper-responsiveness from neuronal hypersensitivity. Under experimental neuro-330 
inflammatory conditions we observed an increased neural response for a given stimulus 331 
which may have a clinical parallel in the form of ‘hypertussia’ observed in patients with 332 
Cough Hypersensitivity Syndrome (CHS) [37]. We have yet to determine if our PNE model 333 
can be rendered ‘hypersensitive’ to low level stimulation. CHS is a disorder gaining 334 
increasing recognition amongst respiratory, allergy, gastroenterology, speech/voice and 335 
otolaryngology healthcare professionals[38].  There is a need to improve our understanding 336 
of the neurobiology of this condition and we believe the novel techniques we report in this 337 
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manuscript and the clinical relevance of our experimental findings will be of interest to those 338 
working in this field.   339 
 340 
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FIGURE LEGENDS 448 
Figure 1: hDPSCs undergo both morphological and phenotype changes during neuronal 449 
differentiation to become functional PNEs. hDPSCs have a fibroblastic morphology 450 
consisting of splayed multipolar elongations (A). Following neuronal differentiation the cells 451 
lose this shape and take on a typical bipolar neuronal morphology consisting of a swollen cell 452 
body and axon-like projections (B). Undifferentiated hDPSCs express the fibroblast marker 453 
FSP (C). This FSP expression is lost during neuronal differentiation and is no longer 454 
expressed in PNEs (D). Prior to neuronal differentiation, hDPSCs do not express the specific 455 
neuronal markers PGP9.5 (E) or synaptophysin (G), which are present in PNE cultures (F and 456 
H respectively). PNEs exhibit voltage-activated Na+ currents following 7 days differentiation. 457 
Family of inward currents recorded from a PNE following a series of 500 ms depolarising 458 
voltage steps from an initial holding potential -120 mV to 55 mV in 5 mV increments (I). 459 
This response, in the same cells, was completely inhibited in the presence of TTX (1 µM; J). 460 
I-V relationships in the absence and presence of TTX normalised against cell capacitance (K; 461 
n=7; mean cell capacitance: 38 pF, SEM: 2.85 (measured using pClamp software)). Bars 462 
represent SEM, ** P < 0.01, *** P < 0.001. TRPV1 expression in PNEs was shown by 463 
immunofluorescence (L). Whole cell patch clamping recording was carried out on PNEs to 464 
investigate the functional expression of TRPV1 channels. Addition of the TRPV1 agonist 465 
capsaicin during voltage ramp protocols increased both inward and outward membrane 466 
currents. This response was inhibited in the presence of the TRPV1 antagonist capsazepine 467 
(M). Peak currents were measured at -80 mV and 80 mV for statistical analysis (N).  468 
 469 
Figure 2: The presence of TRPA1 channel proteins in PNEs was confirmed using 470 
immunofluorescence (A). Whole cell patch clamping recording was carried out on PNEs to 471 
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investigate the functional expression of TRPA1 channels. Addition of the TRPA1 agonist 472 
cinnamaldehyde during voltage ramp protocols increased both inward and outward 473 
membrane currents. This response was inhibited in the presence of the TRPA1 antagonist 474 
HC030031 (B). Peak currents were measured at -80 mV and 80 mV for statistical analysis 475 
(C). Application of cinnamaldehyde to isolated PNEs induced robust rises in [Ca2+]i that were 476 
reversibly inhibited by subsequent application of HC030031 (D,E). In 9 cells the mean 477 
amplitude of cinnamaldehyde responses was significantly reduced from 1.96 ∆F/F0 under 478 
control conditions to 0.02 ∆F/F0 in the presence of HC030031, p<0.01, paired Student’s t test 479 
(F). Error bars represent SEM. Cinnamaldehyde-induced elevations of [Ca
2+
]i were 480 
concentration dependent and the mean EC50 value for this effect was 54 µM (95% confidence 481 
intervals 38-79 µM, n=4, Figs 2G&H, respectively).  482 
 483 
Figure 3: PNE TRPA1 channels become hyper-responsive following 20 minutes incubation 484 
with the pro-inflammatory mediator NGF (100 ng/ml) but this effect was not apparent in 485 
PNEs incubated with NGF for 24hr they did not show heightened responses to 486 
cinnamaldehyde (100 µM; A). This hyper-responsiveness also appears to be independent of 487 
gene expression as no significant changes in TRPA1 gene expression in PNEs were observed 488 
following 6h and 24h NGF (100 ng/ml) treatments (B).  489 
 490 
Figure 4: Poly I:C induces IL8 and IL6 secretion in PNE cultures. Supernatants taken from 491 
PNEs incubated with Poly I:C (2 µg/ml) for 24h showed increased IL8 and IL6 levels than 492 
those taken from untreated PNEs or PNEs incubated with Poly I:C for only 6h (A and B 493 
respectively). PNE TRPA1 channels become hyper-responsive following 20 minutes 494 
incubation with the viral mimetic Poly I:C (2 µg/ml). PNEs treated with Poly I:C 495 
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demonstrated heightened responses to the TRPA1 agonist cinnamaldehyde (100 µM) 496 
compared to those seen in untreated PNEs (C). This hyper-responsiveness appears to be 497 
independent of gene expression as no significant changes in TRPA1 gene expression in PNEs 498 
were observed following 6h and 24h Poly I:C treatments (D). Bars represent SEM, * P < 499 
0.05, ** P < 0.01, *** P<0.005. 500 
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D C 
Figure 4 
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ONLINE SUPPLEMENT 
MATERIALS AND METHODS 
 
Table S1: List of primary antibodies, their source and working dilutions 
Antibody Source 
Host Species Working 
Concentration 
FSP Abcam (UK) Mouse 1:500 
P75 
Advanced Targetting 
Systems (USA) 
Mouse 1:100 
HNK1 Sigma (UK) Mouse 1:100 
AP2α 
Novus Biologicals 
(USA) 
Rabbit 1:50 
PGP9.5 Cedarlane (Canada) Mouse 1:250 
Synaptophysin Dako (UK) Rabbit 1:50 (Pre-diluted) 
SP 
In house (Eedy et al., 
91) 
Rabbit 1:1000 
CGRP Peninsula (USA) Rabbit 1:900 
TRPA1 Abcam (UK) Rabbit  1:100 
TRPV1 Abnova (Taiwan) Mouse 1:100 
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Harvesting total RNA 
RNA was extracted from each sample (1 well) using the Picopure RNA Isolation kit as 
follows: culture medium was removed from PNE cultures and cells were washed with ice 
cold PBS for 5 minutes. Extraction buffer (100 µl) was then added and samples were 
incubated at 42°C for 30 minutes. Each sample was mixed gently using a pipette tip and 
collected in a microcentrifuge tube.  
RNA purification columns were preconditioned by adding conditioning buffer (250 µl) to 
each column membrane. Membranes were incubated with the conditioning buffer for 5 
minutes at room temperature. Columns were then centrifuged at high speed for 1 minute to 
remove buffer. 
70% ethanol (100 µl) was added to each microcentrifuge containing the cell extract and 
samples were mixed gently by pipetting. The mixture was transferred to a preconditioned 
RNA purification column and RNA was bound to the column by centrifuging the column at 
low speed for 2 minutes. Flowthrough was removed by centrifuging the column at high speed 
for 30 seconds.  Wash buffer 1 (100 µl) was added to each column and centrifuged for 1 
minute at 8,000 x g. Wash buffer 2 (100 µl) was then added to each column and samples 
were centrifuged for 1 minute at 8,000 x g. A second aliquot of wash buffer 2 (100 µl) was 
added to each column and centrifuged at high speed for 2 minutes. The purification column 
was then transferred to a collection tube and elution buffer (11 µl) was applied directly to the 
column membrane. Membranes were incubated with elution buffer for 1 minute at room 
temperature before being centrifuged for 1 minute at 1000 x g to ensure complete coverage of 
the membrane with the buffer. RNA was then eluted by centrifuging for 1 minute at high 
speed.  
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RNA was quantified using 2 µl of cDNA solution on a Take3 plate. Absorbance readings at 
260 nm and 280 nm were obtained along with a 260/280 ratio and the concentration of RNA 
per µl. 
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S2: TaqMan primer details 
Gene Reference 
No. 
Chromosome 
No. 
Probe sits 
on exon 
boundary 
Base  
position 
Amplicon 
length 
TRPA1 HS00175798 8 2 - 3 441 124 
TRPV1 HS00218912 17 8 - 9 1540 94 
B2M HS00984230 15 3 - 4 431 81 
GUSB HS00939627 7 8 - 9 1522 96 
 
 
Table S3: Thermal profile for qPCR 
Segment Thermal profile Cycles 
1 2 minutes at 55°C 1 
2 10 minutes at 95°C 1 
3 
15 seconds at 95°C 
1 minute at 60°C 
45 
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Microfluorimetric Calcium Imaging  
[Ca
2+
]i was measured by alternating excitation wavelengths of 340 and 380 nm light 
delivered from a dual monochromator (5 nm bandwidth) using a light chopper. Emitted 
fluorescence was measured from the side port of the microscope via an adjustable rectangular 
window, a filter (510 nm) and a photomultiplier tube (PMT) in the light path. Fluorescence 
equipment was controlled by Acquisition Engine software. Background fluorescence was 
measured at the end of each experiment by exposing the cell to 5 mM MnCl2 and quenching 
the fluorescent dye. Changes in the background-corrected fluorescence emitted at each 
excitation wavelength (R=340/380) was used as a measure of change in cytoplasmic Ca
2+
 
concentrations. 
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Table S4: Cytokine details 
Cytokine Source 
NGF Peprotech (USA) 
TNFα Sigma (UK) 
IL1β Sigma (UK) 
Poly I:C Invivogen (UK) 
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RESULTS 
 
Table S5: The presence of TRPA1 and TRPV1 mRNA in PNEs was confirmed by qPCR  
Channel Ct Average Ct 
TRPA1 
25.785 
25.547 
25.865 
26.055 
24.755 
25.275 
TRPV1 
34.94 
34.644 
34.415 
35.155 
33.935 
34.775 
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FIGURE LEGENDS 
Figure S1: hDPSCs express the neural crest stem cell marker P75 (A) and subpopulations of 
cells express HNK1 (B) and AP2α (C). Scale bars: 50 µm. 
 
Figure S2: PNEs express the neuropeptides SP (A) and CGRP (B), a characteristic of sensory 
neurons. Scale bar 100 µm. 
 
Figure S3: PNEs displayed spontaneous fluctuations in [Ca
2+
]i. Viability of PNEs was determined 
through the observation of increases in [Ca
2+
]i in the absence of agonist challenges. Figures A and B 
are representative traces of the varying degrees of spontaneous activity observed in PNEs. 
 
Figure S4: Changes in intracellular Ca
2+
 levels ([Ca
2+
]i) in response to capsaicin were investigated in 
PNEs demonstrating spontaneous activity. Stimulation with capsaicin evoked an instantaneous 
increase in [Ca2+]i levels (A). [Ca
2+]i fell back to basal levels immediately after peaking. In the 
presence of the TRPV1 antagonist capsazepine PNEs exhibited an attenuated response to capsaicin 
compared with cells that had not been exposed to the antagonist (B). The change in absorbance ratio 
(∆Ratio) was graphed for statistical analysis to show specific TRPV1 activation in PNEs (C). Bars 
represent SEM, * P < 0.05, ** P < 0.01. 
 
Figure S5: PNEs demonstrating spontaneous activity were stimulated with cinnamaldehyde and an 
instantaneous increase in [Ca2+]i levels was observed (A). [Ca
2+]i fell back to basal levels immediately 
after peaking. In the presence of the TRPA1 antagonist HC030031 PNEs exhibited an attenuated 
response to cinnamaldehyde compared to cells that had not been exposed to the antagonist (B). The 
change in absorbance ratio (∆Ratio) was graphed for statistical analysis to show specific TRPA1 
activation in PNEs (C). Bars represent SEM, * P < 0.05, ** P < 0.01. 
 
Figure S6: PNEs were treated with pro-inflammatory cytokines TNFα and IL1β to determine whether 
the lack of change in TRPA1 gene expression was specific to NGF treated cells. No significant 
changes in TRPA1 gene expression was observed in PNEs treated with either TNFα or IL1β. Bars 
represent SEM. 
 
Figure S7: PNE TRPV1 channels did not become hyper-responsive following 20 minutes incubation 
with the pro-inflammatory mediator NGF (100 ng/ml) (A). Similarly there were no significant 
changes in TRPV1 gene expression following NGF treatment for 6 or 24 hours (B). Bars represent 
SEM, * P < 0.05. 
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Figure S8: Vehicle controls. PNE currents were not altered in response to 0.001% DMSO alone. 
Currents generated by cinnamaldehyde and capsaicin were included for comparison. Bars 
represent SEM. 
 
Figure S9: PNEs were treated with a range of Poly I:C concentrations (2 µg/ml – 20 µg/ml) 
in order to determine the optimal working concentration for experiments. IL8 release was 
used a measure of response. PNEs treated with 2 µg/ml PolyI:C generated the largest 
response in terms of IL8 release compared to 10 µg/ml and 20 µg/ml and thus was selected 
for use in further experiments. Bars represent SEM, *** P < 0.001. 
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FIGURES 
 
Figure S1 
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 Figure S4 
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